160P Predicting immune-related adverse events using biomarkers in early-phase cancer immunotherapy trials.

Autor:	Fairfax, B.P.1 (AUTHOR), Schmid, V.C.2 (AUTHOR), Lamparter, D.F.2 (AUTHOR), Kam-Thong, T.2 (AUTHOR), Scepanovic, P.2 (AUTHOR), Duchateau-Nguyen, G.2 (AUTHOR), Roller, A.2 (AUTHOR), Mohindra, R.3 (AUTHOR), Karanikas, V.4 (AUTHOR), Heinzmann, D.5 (AUTHOR), Adams, C.6 (AUTHOR), Mycroft, S.L.7 (AUTHOR), Städler, N.2 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 2, Vol. 35, pS279-S279. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu